Identification of Lynch Syndrome Among Patients With Colorectal Cancer
Leticia Moreira(Universitat de Barcelona), Antoni Castells(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), John L. Hopper(The University of Melbourne), Lauri A. Aaltonen(Varsinais-Suomen Sairaanhoitopiiri), Noralane M. Lindor(Mayo Clinic in Arizona), Maurizio Ponz de Leòn(University of Modena and Reggio Emilia), Montserrat Andreu(Universitat Pompeu Fabra), John A. Baron(University of North Carolina at Chapel Hill), Shanaka R. Gunawardena(Mayo Clinic), Francesc Balaguer(Universitat de Barcelona), Robert W. Haile(University of Southern California), Vı́ctor Moreno(Ajuntament de L’Hospitalet), John D. Potter(Fred Hutch Cancer Center), Polly A. Newcomb(Fred Hutch Cancer Center), Loı̈c Le Marchand(University of Hawaiʻi at Mānoa), Daniel D. Buchanan(The Royal Melbourne Hospital), Albert de la Chapelle(Université Claude Bernard Lyon 1), Dennis J. Ahnen(University of Colorado Denver), Stephen N. Thibodeau(Mayo Clinic in Arizona), Mark A. Jenkins(The University of Melbourne), Heather Hampel(City of Hope), Anil K. Rustgi(California University of Pennsylvania), Steven Gallinger(Ontario Institute for Cancer Research)
Cited by 559
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
|JNCI Journal of the National Cancer Institute|1995|3.4k